Jiangkun Dai
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Catalytic C–H Functionalization Methods
- Multicomponent Synthesis of Heterocycles
Papers in
-
- Antimicrobial Peptides and Activities 3
Jiangkun Dai
37 papers receiving 877 citations
Peers
Comparison fields: 5 of 94
- Toxicology 52
- Organic Chemistry 400
- Microbiology 43
- Pharmacology 114
- Molecular Biology 452
Countries citing papers authored by Jiangkun Dai
This map shows the geographic impact of Jiangkun Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiangkun Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiangkun Dai more than expected).
Fields of papers citing papers by Jiangkun Dai
This network shows the impact of papers produced by Jiangkun Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiangkun Dai. The network helps show where Jiangkun Dai may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiangkun Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 5 | |
| 7 | 2023 | 18 | |
| 8 | 2023 | 8 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 65 | |
| 14 | 2020 | 12 | |
| 15 | 2019 | 154 | |
| 16 | 2018 | 33 | |
| 17 | 2018 | 19 | |
| 18 | 2018 | 45 | |
| 19 | 2018 | 22 | |
| 20 | 2014 | 9 |
About Jiangkun Dai
Jiangkun Dai is a scholar working on Toxicology, Microbiology, Molecular Biology, Complementary and alternative medicine and Immunology, having authored 40 papers that have together received 888 indexed citations. Recurring topics across this work include Synthesis and bioactivity of alkaloids (17 papers), Phytochemical compounds biological activities (10 papers), Cancer therapeutics and mechanisms (8 papers), Toxin Mechanisms and Immunotoxins (6 papers), Essential Oils and Antimicrobial Activity (4 papers), Natural product bioactivities and synthesis (3 papers), Biochemical and Structural Characterization (3 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Toxicology (52 citations), Organic Chemistry (400 citations), Microbiology (43 citations), Pharmacology (114 citations) and Molecular Biology (452 citations). Jiangkun Dai has collaborated with scholars based in China, Macao and United Kingdom. Frequent co-authors include Wenjia Dan, Junru Wang, Uwe Schneider, Na Li, Jian‐Bo Wan, Xiaohui Qi, Yu-Jie Xu, Rui Han, Yunyun Zhang and Shijun Wang. Their work appears in journals such as European Journal of Medicinal Chemistry, Molecules, Bioorganic & Medicinal Chemistry Letters, Bioorganic Chemistry and Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.